The combination of thioridazine and carboplatin induced apoptosis by downregulating c-FLIP and Mcl-1 [66], indicating that Mcl-1 can be used as a molecular target of combination therapy in oral cancer. Here, MCL1 is linked to lip and oral cavity carcinoma.